Amplifier Therapeutics
New York
About Amplifier Therapeutics
Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules to treat aging-related disorders such as metabolic problems, cardiovascular diseases, kidney diseases, and cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $33.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: amplifier-tx.com
Industries & Categories
Biopharma, Biotechnology, Life Science
Canonical: https://fsome.com/organization/amplifier-therapeutics-72646 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.